Home » Topics » BioWorld

BioWorld
RSS

NEWS BRIEFS

May 30, 1991

CEO RESIGNS FROM QUADRA LOGIC

May 30, 1991

NIH ENTERS AZT PATENT DISPUTE

May 30, 1991

STEM CELL DUPLICATION FOR BETTER CATTLE

May 29, 1991

ANTI-B CELL MAbs REDUCE LYMPHOMA

May 29, 1991

CEPHALON TO RESEARCH ENZYMES

May 29, 1991

NEWS BRIEFS

May 29, 1991

APPOINTMENTS AND ADVANCEMENTS

May 29, 1991

NEWS BRIEFS

May 28, 1991

APPOINTMENTS AND ADVANCEMENTS

May 28, 1991

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 13, 2026.
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
NRF2 activators reported in Vailima Peninsula patent
BioWorld Science
Vailima Peninsula Pty Ltd. has discovered new nuclear factor erythroid 2-related factor 2 (NFE2L2; NRF2) activators potentially useful for the treatment of...